Ортостатическая гипотония. Часть 2: диагностика и лечение

Г. А. Головина; О. Н. Жадан; К. А. Заргарян; О. А. Кравченко; Н. Е. Трипольская

doi:10.35401/2500-0268-2020-19-3-77-85

Ортостатическая гипотония. Часть 2: диагностика и лечение

Г. А. Головина, О. Н. Жадан, К. А. Заргарян, О. А. Кравченко, Н. Е. Трипольская

https://doi.org/10.35401/2500-0268-2020-19-3-77-85

Полный текст:

PDF (Rus) |

сгенерировать QR код

Аннотация

Ортостатическая гипотония (ОГ) чаще всего протекает бессимптомно, в связи с чем выявить ее возможно только при проведении ортостатических проб. Важно определить этиологию ОГ в каждом отдельном случае, так как лечение заболевания, вызвавшего ОГ, позволит улучшить прогноз здоровья пациента. Целью терапии ОГ выступает улучшение функционального состояния больного, уменьшение симптомов и снижение риска падений и обмороков, а не достижение определенных показателей артериального давления. Информированность врачей различных специальностей о способах диагностики ОГ, медикаментозных и немедикаментозных методах ее лечения позволит улучшить качество жизни пациентов, для которых характерно это состояние.
Первая часть обзорного исследования, посвященного ортостатической гипотонии, опубликована в №4 журнала «Инновационная медицина Кубани» за 2018 г.

Ключевые слова

ортостатическая гипотония, обморок, ортостатическая проба

Список литературы

1. Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope - update 2004. Europace. 2004;6:467-537. PMID: 15519256. https://doi.org/10.1016/j.eupc.2004.08.008

2. Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631-71. PMID: 19713422. PMCID: PMC3295536. https://doi.org/10.1093/eurheartj/ehp298

3. Shen W-K, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017;136:e60-e122. PMID: 28280231. https://doi.org/10.1161/CIR.0000000000000499

4. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883-948. PMID: 29562304. https://doi.org/10.1093/eurheartj/ehy037

5. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69-72. PMID: 21431947. https://doi.org/10.1007/s10286-011-0119-5

6. Shibao C, Lipsitz LA, Biaggioni I. ASH position paper: evaluation and treatment of orthostatic hypotension. J Clin Hypertens (Greenwich). 2013;15:147-53. PMID: 23458585. https://doi.org/10.1111/jch.12062

7. Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848-60. PMID: 26271068. https://doi.org/10.1016/j.jacc.2015.06.1084

8. Goldstein DS, Sharabi Ye. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119:139-46. PMID: 19124673. PMCID: PMC4182314. https://doi.org/10.1161/CIRCULATIONAHA.108.805887

9. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 8-й выпуск. Сахарный диабет. 2017;20(1S):1-112. https://doi.org/10.14341/DM221S1

10. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159-219. PMID: 23771844. https://doi.org/10.1093/eurheartj/eht151

11. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021-104. PMID: 30165516. https://doi.org/10.1093/eurheartj/ehy339

12. Valbusa F, Labat C, Salvi P, et al. Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens. 2012;30:53-60. PMID: 22080223. https://doi.org/10.1097/HJH.0b013e32834d3d73

13. Romero-Ortuno R, O’Connell MD, Finucane C, Soraghan C, Fan ChW, Kenny RA. Insights into the clinical management of the syndrome of supine hypertension - orthostatic hypotension (SH-OH): the Irish Longitudinal Study on Ageing (TILDA). BMC Geriatr. 2013;13:73. PMID: 23855394. PMCID: PMC3716968. https://doi.org/10.1186/1471-2318-13-73

14. Canney M, O’Connell MD, Murphy CM, et al. Single agent antihypertensive therapy and orthostatic blood pressure behaviour in older adults using beat-to-beat measurements: the Irish Longitudinal Study on Ageing. PLoS One. 2016;11:e0146156. PMID: 26730962. PMCID: PMC4701419. https://doi.org/10.1371/journal.pone.0146156

15. Fogari R, Zoppi A, Mugellini A, et al. Efficacy and safety of two treatment combinations of hypertension in very elderly patients. Arch Gerontol Geriatr. 2009;48:401-5. PMID: 18457886. https://doi.org/10.1016/j.archger.2008.03.012

16. Di Stefano C, Milazzo V, Totaro S, et al. Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic. J Hum Hypertens. 2015;29:599-603. PMID: 25631221. https://doi.org/10.1038/jhh.2014.130

17. Kamaruzzaman Sh, Watt H, Carson C, Ebrahim Sh. The association between orthostatic hypotension and medication use in the British Women’s Heart and Health Study. Age Ageing. 2010;39:51-6. PMID: 19897539. https://doi.org/10.1093/ageing/afp192

18. Heseltine D, Bramble MG. Loop diuretics cause less postural hypotension than thiazide diuretics in the frail elderly. Curr Med Res Opin. 1988;11:232-5. PMID: 3215040. https://doi.org/10.1185/03007998809114241

19. Bird ST, Delaney JA, Brophy JM, Etminan M, Skeldon SC, Hartzema AG. Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology. BMJ. 2013;347:f6320. PMID: 24192967. PMCID: PMC3817852. https://doi.org/10.1136/bmj.f6320

20. Woolcott JC, Richardson KJ, Wiens MO, et al. Metaanalysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169:1952-60. PMID: 19933955. https://doi.org/10.1001/archinternmed.2009.357

21. de Bruïne ES, Reijnierse EM, Trappenburg MC, et al. Standing up slowly antagonises initial blood pressure decrease in older adults with orthostatic hypotension. Gerontology. 2017;63:137-43. PMID: 27756060. https://doi.org/10.1159/000450642

22. Wieling W, van Dijk N, Thijs RD, de Lange FJ, Krediet CT, Halliwill JR. Physical countermeasures to increase orthostatic tolerance. J Intern Med. 2015;277:69-82. PMID: 24697914. https://doi.org/10.1111/joim.12249

23. Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans: a sympathetic reflex? Circulation. 2000;101:504-9. PMID: 10662747. https://doi.org/10.1161/01.cir.101.5.504

24. Jordan J. Acute effect of water on blood pressure. What do we know? Clin Auton Res. 2002;12:250-5. PMID: 12357278. https://doi.org/10.1007/s10286-002-0055-5

25. Podoleanu C, Maggi R, Brignole M, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized singleblind controlled study. J Am Coll Cardiol. 2006;48:1425-32. PMID: 17010806. https://doi.org/10.1016/j.jacc.2006.06.052

26. Figueroa JJ, Basford JR, Low PhA. Preventing and treating orthostatic hypotension: a easy as A, B, C. Cleve Clin J Med. 2010;77:298-306. PMID: 20439562. https://doi.org/10.3949/ccjm.77a.09118

27. Ten Harkel AD, van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992;232:139-45. PMID: 1506810. https://doi.org/10.1111/j.1365-2796.1992.tb00563.x

28. Omboni S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci (Lond). 2001;101:609-18. PMID: 11724647.

29. Newton JL, Frith J. The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2018;91:e652-e656. PMID: 30006412. PMCID: PMC6105042. https://doi.org/10.1212/WNL.0000000000005994

30. Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med. 1993;95:38-48. PMID: 7687093. https://doi.org/10.1016/0002-9343(93)90230-m

31. Low PhA, Gilden JL, Freeman R, Sheng K-N, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study [published correction appears in JAMA. 1997;278:388. https://doi.org/10.1001/jama.1997.03550050050031]. JAMA. 1997;277:1046-51. PMID: 9091692. https://doi.org/10.1001/jama.1997.03540370036033

32. Wright RA, Kaufmann HC, Perera R, et al. A doubleblind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology. 1998;51:120-4. PMID: 9674789. https://doi.org/10.1212/wnl.51.1.120

33. van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10:35-42. PMID: 1075642. https://doi.org/10.1007/BF02291388

34. Axelrod FB, Goldberg JD, Rolnitzky L, et al. Fludrocortisone in patients with familial dysautonomia - assessing effect on clinical parameters and gene expression. Clin Auton Res. 2005;15:284-91. PMID: 16032383. https://doi.org/10.1007/s10286-005-0288-1

35. Finke J, Sagemüller I. Fludrocortisone in the treatment of orthostatic hypotension: ophthalmodynamography during standing (author’s transl). Dtsch Med Wochenschr. 1975;100:1790-2. PMID: 1098888. https://doi.org/10.1055/s-0028-1106461

36. Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;83:328- 35. PMID: 24944260. PMCID: PMC4115605. https://doi.org/10.1212/WNL.0000000000000615

37. Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson’s disease (nOH306B). Mov Disord. 2015;30:646-54. PMID: 25487613. https://doi.org/10.1002/mds.26086

38. Biaggioni I, Freeman R, Mathias CJ, Low Ph, Hewitt LA, Kaufmann H. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015;65:101-7. PMID: 25350981. PMCID: PMC4354798. https://doi.org/10.1161/HYPERTENSIONAHA.114.04035

39. Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson’s disease (NOH306A). J Parkinsons Dis. 2014;4:57-65. PMID: 24326693. https://doi.org/10.3233/JPD-130259

40. Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ. Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303). J Parkinsons Dis. 2016;6:751-759. PMID: 27636856. https://doi.org/10.3233/JPD-160860

41. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294-8. PMID: 12933939. PMCID: PMC1738643. https://doi.org/10.1136/jnnp.74.9.1294

42. Singer W, Sandroni P, Opfer-Gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63:513-8. PMID: 16476804. https://doi.org/10.1001/archneur.63.4.noc50340

43. Schreglmann SR, Büchele F, Sommerauer M, et al. Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson’s disease - a randomized controlled trial. Eur J Neurol. 2017;24:545-51. PMID: 28224720. https://doi.org/10.1111/ene.13260

44. Shibao C, Okamoto LE, Gamboa A, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010;56:847-51. PMID: 20837887. PMCID: PMC2959129. https://doi.org/10.1161/HYPERTENSIONAHA.110.154898

45. Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264:1567-82. PMID: 28050656. PMCID: PMC5533816. https://doi.org/10.1007/s00415-016-8375-x

46. Ramirez CE, Okamoto LE, Arnold AC, et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014;64:1235- 40. PMID: 25185131. PMCID: PMC4231172. https://doi.org/10.1161/HYPERTENSIONAHA.114.04225

47. Okamoto LE, Shibao C, Gamboa A, et al. Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure. Hypertension. 2012;59:650-6. PMID: 22311903. PMCID: PMC3312003. https://doi.org/10.1161/HYPERTENSIONAHA.111.184812

48. Sakakibara R, Matsuda Sh, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res. 2003;13:106-8. PMID: 12720096. https://doi.org/10.1007/s10286-003-0052-3

49. Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an α-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50:54-61. PMID: 17515447. https://doi.org/10.1161/HYPERTENSIONAHA.107.091355

Для цитирования:

Головина Г.А., Жадан О.Н., Заргарян К.А., Кравченко О.А., Трипольская Н.Е. Ортостатическая гипотония. Часть 2: диагностика и лечение. Инновационная медицина Кубани. 2020;(3):77-85. https://doi.org/10.35401/2500-0268-2020-19-3-77-85

For citation:

Golovina G.A., Zhadan O.N., Zargaryan K.A., Kravchenko O.A., Tripolskaya N.Ye. Orthostatic hypotension. Part 2: diagnosis and treatment. Innovative Medicine of Kuban. 2020;(3):77-85. (In Russ.) https://doi.org/10.35401/2500-0268-2020-19-3-77-85

Контент доступен под лицензией Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 2541-9897 (Online)

Логин
Пароль
	Запомнить меня
Регистрация нового пользователя Забыли Ваш пароль?

Инновационная медицина Кубани

Ортостатическая гипотония. Часть 2: диагностика и лечение

Полный текст:

Аннотация

Ключевые слова

Об авторах

Список литературы

Рецензия

Для цитирования:

For citation:

Войти

Инновационная медицина Кубани

Ортостатическая гипотония. Часть 2: диагностика и лечение

Полный текст:

Аннотация

Ключевые слова

Об авторах

Список литературы

Рецензия

Для цитирования:

For citation:

Использование куки-файлов